Evidence map›Paper›PMID 18412543›Full record

ArticleThe Biochemical journal2008

Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin.

Cicerone Tudor, Nicole Lerner-Marmarosh, Yves Engelborghs, Peter E M Gibbs, Mahin D Maines

Open access · greenAbstract read
In one paragraph

Article in The Biochemical journal, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 77 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Review
  5. Protein Oxidation in Aging and Alzheimer's Disease Brain.Antioxidants (Basel, Switzerland) · 2024
    Review
  6. Review
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Review
  13. Article
  14. Review
  15. Article
  16. Article
  17. Interplay of Heme with Macrophages in Homeostasis and Inflammation.International journal of molecular sciences · 2020
    Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Cicerone TudorLaboratory of Biomolecular Dynamics, Katholieke Universiteit Leuven, Leuven, Belgium.
Nicole Lerner-Marmarosh
Yves Engelborghs
Peter E M Gibbs
Mahin D Maines
KU Leuven · BE

Funding

Regulation of Cell Signaling by Human Biliverdin ReductaseR01ES004066 · NIEHS · UNIVERSITY OF ROCHESTER · PI MAINES, MAHIN D. · 1986 to 2015
$5.3M
Regulation of heme oxygenase-1 by biliverdin reductaseR01ES012187 · NIEHS · UNIVERSITY OF ROCHESTER · PI MAINES, MAHIN D. · 2003 to 2011
$2.6M
NIEHS NIH HHS ES012187NIEHS NIH HHS ES04066NIEHS NIH HHS R01 ES004066NIEHS NIH HHS R01 ES012187
6 · The paper itself

Abstract

hBVR (human biliverdin reductase) is an enzyme that reduces biliverdin (the product of haem oxygenases HO-1 and HO-2 activity) to the antioxidant bilirubin. It also functions as a kinase and as a transcription factor in the MAPK (mitogen-activated protein kinase) signalling cascade. Fluorescence correlation spectroscopy was used to investigate the mobility of hBVR in living cells and its function in the nuclear transport of haematin for induction of HO-1. In transiently transfected HeLa cells only kinase-competent hBVR translocates to the nucleus. A reduced mobility in the nucleus of haematin-treated cells suggests formation of an hBVR-haematin complex and its further association with large nuclear components. The binding of haematin is specific, with the formation of a 1:1 molar complex, and the C-terminal 7-residue fragment KYCCSRK(296) of hBVR contributes to the binding. The following data suggest formation of dynamic complexes of hBVR-haematin with chromatin: (i) the reduction of hBVR mobility in the presence of haematin is greater in heterochromatic regions than in euchromatic domains and (ii) hBVR mobility is not retarded by haematin in nuclear lysates that contain only soluble factors. Moreover, hBVR kinase activity is stimulated in the presence of double-stranded DNA fragments corresponding to HO-1 antioxidant and HREs (hypoxia response elements), as well as by haematin. Experiments with nuclear localization, export signal mutants and si-hBVR [siRNA (small interfering RNA) specific to hBVR] indicate that nuclear localization of hBVR is required for induction of HO-1 by haematin. Because gene regulation is energy-dependent and haematin regulates gene expression, our data suggest that hBVR functions as an essential component of the regulatory mechanisms for haem-responsive transcriptional activation.

Indexed as

Biological TransportCell NucleusCytoplasmGene Expression Regulation, EnzymologicGreen Fluorescent ProteinsHeLa CellsHemeHeme Oxygenase-1HemeproteinsHeminHeterochromatinHumansMicroscopy, ConfocalOxidoreductases Acting on CH-CH Group DonorsProtein BindingRecombinant Fusion Proteinsbiliverdin reductaseGreen Fluorescent ProteinsHemeHeme Oxygenase-1HemeproteinsHeminHeterochromatinOxidoreductases Acting on CH-CH Group DonorsRecombinant Fusion Proteins

Identifiers

PMID18412543
PMCPMC2723824
OpenAlexW2087720482

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.